Clinical Research Admin

Looking for something?

Currently Enrolling Studies

Expand each section to learn more.

Neovascular Age-Related Macular Degeneration (nAMD or Wet AMD)

Ocular SOL-R / OTX-TKI-2023-AMD-303 / Ocular Therapeutix, Inc.

Study Details – ClinicalTrials.gov

Full Eligibility Criteria

Daybreak / KS301P109 / Kodiak Sciences, Inc.

Study Details – ClinicalTrials.gov

Full Eligibility Criteria

Protocol AO / DRCR Retina Network / Jaeb Center for Health Research.

Study Details – ClinicalTrials.gov

Full Eligibility Criteria

Geographic Atrophy (GA)

Archer II / ANX007-GA-02 / Annexon, Inc.

Study Details – ClinicalTrials.gov

Full Eligibility Criteria

Active Studies – Not Currently Enrolling

Neovascular Age-Related Macular Degeneration (nAMD or Wet AMD)

Ocular SOL / OTX-TKI-2023-AMD-301 / Ocular Therapeutix, Inc.

Study Details – ClinicalTrials.gov

Full Eligibility Criteria

Eye Clinic of Wisconsin complies with applicable Federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability, or sex. Eye Clinic of Wisconsin does not exclude people or treat them differently because of race, color, national origin, age, disability, or sex. Eye Clinic of Wisconsin provides free aids and services to people with disabilities to communicate effectively with us, such as; qualified sign language interpreters, written information in other formats (large print, audio, accessible electronic formats, other formats), and free language services to people whose primary language is not English.